NIH-funded research R21 grant

Creating blood stem cells from human stem cells in the lab

Official title: A microRNA-mediated approach towards generating functional hematopoietic stem cells from human pluripotent stem cells in vitro

Funded at Cedars-Sinai Medical Center · NIH-10810589 · Data updated 2026-11-12

This study is working on a way to create blood stem cells in the lab that could be used for transplants, which might help patients with blood disorders get the treatment they need without having to wait for a matching donor.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startSeptember 30, 2023
Project endSeptember 29, 2025
Funding year2023
Award (this year)$459,250
NIH project number1R21AG078872-01A1
Project IDNIH-10810589 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients suffering from blood diseases who require hematopoietic stem cell transplants.

Less likely to help

Patients with non-hematological conditions or those who do not require stem cell transplantation may not benefit from this research.

What this research studies

This research aims to develop a method for producing transplantable hematopoietic stem cells (HSCs) from human pluripotent stem cells (PSCs) in a laboratory setting. By understanding the molecular differences between functional HSCs and those generated in vitro, the researchers will manipulate specific microRNAs to enhance the development of functional blood stem cells. This approach could potentially eliminate the need for patients to wait for a compatible bone marrow donor, providing a more accessible treatment option for various blood disorders.

Why it matters

Potential benefit: If successful, this research could provide a reliable source of blood stem cells for patients with hematological disorders, significantly improving treatment accessibility.

How similar studies have gone: While the approach of generating functional HSCs from PSCs is innovative, preliminary data suggests that similar strategies have shown promise in related research.

Where this research is happening

  • Cedars-Sinai Medical Center
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Panopoulos, Athanasia — Cedars-Sinai Medical Center
  • Study coordinator: Panopoulos, Athanasia

Related research

Other NIH-funded projects on the same topics.

  • Lipid signals that control acetyl-CoA and fat metabolism in NAFLD

    A study exploring how membrane lipids influence acetyl-CoA metabolism to understand and potentially treat nonalcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591466

  • Them1’s role in fat metabolism and MASLD progression

    Aims to understand how a fat-regulating protein (Them1) affects energy use in fat and liver, and how this could contribute to MASLD in people who are overweight.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591395

  • Biomarker-guided Immunosuppression in Kidney Transplant Patients

    A multicenter study in kidney transplant recipients is testing whether a biomarker score from HLA-DR/DQ can guide changes in immunosuppression to reduce rejection risk and drug toxicity.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11550940

  • Alpha5 integrin's role in ALS: how a cell switch worsens disease

    Aims to understand how a specific protein called alpha5 integrin in immune cells affects ALS progression and whether blocking it can help extend life.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11540166

  • Chlamydia pneumoniae infection and Alzheimer's disease progression

    This project looks at whether a common lung infection, Chlamydia pneumoniae, might influence Alzheimer's disease in people and what that could mean for treatment.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11538116

  • Them1 Inhibitors to Help Treat Fatty Liver Disease

    Aims to develop and test small molecule drugs that block Them1 to help people with non-alcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11519341

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.